FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine. In experiment, by multiple impedance measurement of malignant and benign focal lesions followed by calculation of average value before introduction of ethyl alcohol - Z1av. and after introduction - Z2av., factor K is calculated as a Z2av. to Z1av. impedances relation. And if the K is more or equal to 1.27, sclerotherapy is considered to be effective. The method ensures to control effectively the ethanol 96% based sclerotherapy manipulation process.
EFFECT: possibility to control effectively the ethanol 96% based sclerotherapy manipulation process.
1 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SCLEROTHERAPY OF LARGE HEPATIC METASTASES | 2002 |
|
RU2212853C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF TUMOURS | 2012 |
|
RU2492806C1 |
| SCLEROTHERAPY METHOD FOR TREATING THE CASES OF HEPATIC AND RENAL CYSTS | 2001 |
|
RU2200031C2 |
| METHOD OF DIAGNOSING TOXIC HEPATATIS IN EXPERIMENT | 2008 |
|
RU2382595C1 |
| METHOD FOR ESTIMATING METASTATIC LIVER CANCER TREATMENT RATES | 2009 |
|
RU2400130C1 |
| METHOD FOR APPLYING SCLEROTHERAPY TO MALIGNANT FOCAL HEPATIC INJURIES | 1999 |
|
RU2178674C2 |
| METHOD OF EVALUATING ELECTROCHEMICAL LYSIS EFFICIENCY | 2009 |
|
RU2400823C1 |
| METHOD OF TREATING ANGIODYSPLASIAS | 2013 |
|
RU2535105C2 |
| METHOD FOR MAKING PUNCTURE CANAL ABLASTIC AFTER PERFORMING BIOPSY | 1998 |
|
RU2158538C2 |
| COMPOSITION FOR CHEMICAL TISSUE ABLATION AND ITS APPLICATION | 2022 |
|
RU2791906C1 |
